Endothelin Blockade in Patients With Single Ventricle Physiology
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Recent studies have shown beneficial effects of sildenafil in patients with single ventricle
congenital heart disease. The purpose of this study is to determine whether Bosentan, a drug
with similar effects, will have similar benefit in this patient population.